Phase 2 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You fully understand what the study involves and are willing to sign a consent form agreeing to take part.
- You are a woman between 18 and 75 years of age.
- You are able to carry out daily activities mostly or fully on your own, with little or no limitation from your illness (confirm with trial site).
- You have been diagnosed with advanced cervical cancer — specifically a type confirmed by a tissue or cell sample — including squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma.
Who may not be able to join:
- The doctor running the trial decides, for any reason, that it would not be appropriate for you to take part.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jason Wu, Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phone: +86-0512-57309965
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Adverse Event (AE); Objective response rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.